Global Down Syndrome

Winter 2016

Issue link: https://viewer.e-digitaledition.com/i/657802

Contents of this Issue

Navigation

Page 10 of 31

CONTINUED FROM PAGE 9 SCIENCE SNPs Continued TOO MUCH RCAN1 LEADS TO POOR INNERVATION Most investigations of neural anomalies in trisomy 21, the clinical name for Down syndrome, have focused on the central nervous system, but dysfunction of the peripheral nervous system is also a common feature in people with Down syndrome. Specifically, defects in the sympathetic peripheral nervous system have been linked to problems with regulation of heart rate and blood pressure. Researchers at Johns Hopkins University have found that excess activity of the RCAN1 gene, which resides on chromosome 21, impairs the survival and function of neurons in the peripheral system. Using genetic engineering, they corrected RCAN1 levels in Down syndrome mice and observed improved neuronal survival and innervation. These results uncover a key molecular link between a specific gene on chromosome 21 and developmental deficits in the peripheral nervous system in Down syndrome. Nature Communications, DECEMBER 2015 NEW TREATMENT FOR ALOPECIA AREATA IN SIGHT People with trisomy 21 have an increased risk of developing alopecia areata, an autoimmune condition that causes premature hair loss. While studying this phenomenon in mice, researchers at the Columbia University Medical Center discovered that immune cells were fueled by enzymes that could be targeted by a class of drugs known as JAK inhibitors. The researchers administered FDA-approved JAK inhibitors, and the mice regrew their hair with long-lasting effect. The researchers then launched a pilot clinical trial to test one of the inhibitors, ruxolitinib, in humans. Results published in Nature Medicine showed that three of the participants experienced complete hair regrowth within five months. Larger clinical trials will determine whether JAK inhibitors can be widely used for the treatment of alopecia areata. Nature Medicine, AUGUST 2014; Science Advances OCTOBER 2015 GET CONNECTED Want to be part of this exciting new research? Create an account for yourself or a loved one on the National Institutes of Health's DS- Connect ® registry, a secure online database of health information that will serve as a recruitment tool for scientists involved in the Biomarkers of Alzheimer's Disease in Adults with Down Syndrome Initiative. Learn more at ds-connect.com. psychology at Louisiana State University and performed subsequent residency and fellowship training in neuropsychology. During her training, Dr. Ryan became interested in dementia and diseases of aging, such as Alzheimer's disease. She has served at the NIA as Chief of the Dementias of Aging Branch since 2013 and oversees the NIA's substantive and growing basic and clinical research programs pertaining to Alzheimer's disease. A NATURAL PARTNERSHIP Drs. Parisi and Ryan built a rapport working together as members of the trans-NIH Working Group on Down Syndrome, which consists of 10 institutes within the NIH that are furthering Down syndrome research. When presented with the opportunity to develop a committee and explore funding for Alzheimer's disease research in adults with Down syndrome, they welcomed the assignment. "Alzheimer's disease is a serious health concern for people with Down syndrome," Dr. Parisi said. "The NIA and NICHD are motivated by a joint desire to determine who is at greatest risk for Alzheimer's disease, which will allow us to ultimately prevent or treat it so families no longer face its devastating consequences." With the full support of the directors of the NIA and NICHD, Drs. Parisi and Ryan jointly developed a proposal to request grant applications to study biomarkers of Alzheimer's disease in Down syndrome. Each application went through the NIH's peer-review process, and awards were announced in September 2015. "The researchers leading these efforts are truly experts in their fields," Dr. Ryan said. "They're working together to maximize their knowledge, and we couldn't be happier to fund these initiatives." For more information about the NIA's work on Alzheimer's disease, visit nia.nih.gov/research/dn. To learn more about the ongoing Down syndrome research funded by the NICHD, visit nichd.nih.gov, select "A–Z Health and Research Topics," and choose "Down syndrome." GLOBALDOWNSYNDROME.ORG 11

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Winter 2016